Optimising Paediatric HIV Treatment: Recent Developments and Future Directions.

Paediatr Drugs · 2024 · PMC11519159 · PMID 39436531

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the CHAPAS-4 trial, DRV/r showed a trend to superiority in virological suppression (<400 c/mL) compared with LPV/r and ATV/r arms combined (adjusted difference 5.6% [95% confidence interval 0.3, 11.0]; p = 0.04) [ 20 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.